Closed-loop control strategy for type i diabetic patients

Research output: Contribution to journalArticle

Abstract

Administering 'optimal' amount of insulin to maintain the blood glucose (BG) concentration in the normoglycaemic range is vital in type I diabetics. Insulin injection therapy is widely practiced for the maintenance of blood glucose levels within the normoglycemic range (70-100 mg/dL) for type I diabetics. Current insulin therapy for patients with type I diabetes often results in high variability in blood glucose concentrations and may cause hyperglycemic/hypoglycemic episodes. Closing the glucose control loop with a fully automated electro-mechanical pancreas will improve the quality of life for insulin-dependent patients. The performances of the nominal continuous H controller and robust controllers are compared with the proportional-integral-derivative (PID) and internal model control (IMC) controllers. The resulting PID and IMC controllers are designed by considering first order plus delay time (FOPDT) model of the system to be controlled.

Original languageEnglish
Pages (from-to)345-354
Number of pages10
JournalInternational Journal of Medical Engineering and Informatics
Volume6
Issue number4
DOIs
Publication statusPublished - 01-10-2014

Fingerprint

Insulin
Glucose
Blood Glucose
Controllers
Blood
Derivatives
Plant shutdowns
Medical problems
Type 1 Diabetes Mellitus
Hypoglycemic Agents
Pancreas
Time delay
Maintenance
Quality of Life
Injections
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Health Informatics

Cite this

@article{fd80f028914e41b7b880dfc3274a8335,
title = "Closed-loop control strategy for type i diabetic patients",
abstract = "Administering 'optimal' amount of insulin to maintain the blood glucose (BG) concentration in the normoglycaemic range is vital in type I diabetics. Insulin injection therapy is widely practiced for the maintenance of blood glucose levels within the normoglycemic range (70-100 mg/dL) for type I diabetics. Current insulin therapy for patients with type I diabetes often results in high variability in blood glucose concentrations and may cause hyperglycemic/hypoglycemic episodes. Closing the glucose control loop with a fully automated electro-mechanical pancreas will improve the quality of life for insulin-dependent patients. The performances of the nominal continuous H controller and robust controllers are compared with the proportional-integral-derivative (PID) and internal model control (IMC) controllers. The resulting PID and IMC controllers are designed by considering first order plus delay time (FOPDT) model of the system to be controlled.",
author = "Surekha Kamath",
year = "2014",
month = "10",
day = "1",
doi = "10.1504/IJMEI.2014.065438",
language = "English",
volume = "6",
pages = "345--354",
journal = "International Journal of Medical Engineering and Informatics",
issn = "1755-0653",
publisher = "Inderscience Enterprises Ltd",
number = "4",

}

Closed-loop control strategy for type i diabetic patients. / Kamath, Surekha.

In: International Journal of Medical Engineering and Informatics, Vol. 6, No. 4, 01.10.2014, p. 345-354.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Closed-loop control strategy for type i diabetic patients

AU - Kamath, Surekha

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Administering 'optimal' amount of insulin to maintain the blood glucose (BG) concentration in the normoglycaemic range is vital in type I diabetics. Insulin injection therapy is widely practiced for the maintenance of blood glucose levels within the normoglycemic range (70-100 mg/dL) for type I diabetics. Current insulin therapy for patients with type I diabetes often results in high variability in blood glucose concentrations and may cause hyperglycemic/hypoglycemic episodes. Closing the glucose control loop with a fully automated electro-mechanical pancreas will improve the quality of life for insulin-dependent patients. The performances of the nominal continuous H controller and robust controllers are compared with the proportional-integral-derivative (PID) and internal model control (IMC) controllers. The resulting PID and IMC controllers are designed by considering first order plus delay time (FOPDT) model of the system to be controlled.

AB - Administering 'optimal' amount of insulin to maintain the blood glucose (BG) concentration in the normoglycaemic range is vital in type I diabetics. Insulin injection therapy is widely practiced for the maintenance of blood glucose levels within the normoglycemic range (70-100 mg/dL) for type I diabetics. Current insulin therapy for patients with type I diabetes often results in high variability in blood glucose concentrations and may cause hyperglycemic/hypoglycemic episodes. Closing the glucose control loop with a fully automated electro-mechanical pancreas will improve the quality of life for insulin-dependent patients. The performances of the nominal continuous H controller and robust controllers are compared with the proportional-integral-derivative (PID) and internal model control (IMC) controllers. The resulting PID and IMC controllers are designed by considering first order plus delay time (FOPDT) model of the system to be controlled.

UR - http://www.scopus.com/inward/record.url?scp=84908248152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908248152&partnerID=8YFLogxK

U2 - 10.1504/IJMEI.2014.065438

DO - 10.1504/IJMEI.2014.065438

M3 - Article

VL - 6

SP - 345

EP - 354

JO - International Journal of Medical Engineering and Informatics

JF - International Journal of Medical Engineering and Informatics

SN - 1755-0653

IS - 4

ER -